Nu-Med Plus (NUMD) Capital Expenditures (2012 - 2018)
Nu-Med Plus recorded quarterly Capital Expenditures of $1.0 in Q4 2018, up 100.09% quarter-over-quarter from -$1101.0 in Q4 2014.
Nu-Med Plus' Capital Expenditures history runs 4 years deep, the most recent figure standing at $1.0 for Q4 2018.
- In Q4 2018, Capital Expenditures changed N/A year-over-year to $1.0; the TTM figure through Dec 2019 stood at $1.0 (changed 0.0% YoY), while the FY2018 annual figure was -$5025.0, changed N/A from the prior year.
- Capital Expenditures came in at $1.0 for Q4 2018 at Nu-Med Plus, up from -$1101.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $1.0 in Q4 2018 to a low of -$1101.0 in Q4 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 444.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -85.46 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 76.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 86.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 90.20 Mn |
| 10 | Nu-Med Plus | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 1.00 |
| Dec 31, 2018 | 1.00 |
| Dec 31, 2014 | -1,101.00 |
| Dec 31, 2014 | -1,101.00 |
| Dec 31, 2013 | 27,240.00 |
| Dec 31, 2013 | 27,240.00 |
| Sep 30, 2013 | 1,679.00 |
| Sep 30, 2013 | 1,679.00 |
| Dec 31, 2012 | -36.00 |
| Dec 31, 2012 | -36.00 |
| Sep 30, 2012 | 1.00 |
| Sep 30, 2012 | 1.00 |
| Jun 30, 2012 | 18,835.00 |
| Jun 30, 2012 | 18,835.00 |